nodes	percent_of_prediction	percent_of_DWPC	metapath
Meprobamate—ABCB1—breast cancer	0.183	1	CbGaD
Meprobamate—ABCB1—Toremifene—breast cancer	0.0628	0.137	CbGbCtD
Meprobamate—CYP2C19—Lapatinib—breast cancer	0.0568	0.124	CbGbCtD
Meprobamate—ABCB1—Lapatinib—breast cancer	0.0458	0.1	CbGbCtD
Meprobamate—CYP2E1—Tamoxifen—breast cancer	0.0454	0.0993	CbGbCtD
Meprobamate—CYP2E1—Mitoxantrone—breast cancer	0.0443	0.0968	CbGbCtD
Meprobamate—CYP2C19—Tamoxifen—breast cancer	0.0284	0.0622	CbGbCtD
Meprobamate—ABCB1—Vinorelbine—breast cancer	0.0254	0.0556	CbGbCtD
Meprobamate—ABCB1—Tamoxifen—breast cancer	0.023	0.0502	CbGbCtD
Meprobamate—ABCB1—Mitoxantrone—breast cancer	0.0224	0.049	CbGbCtD
Meprobamate—ABCB1—Gemcitabine—breast cancer	0.0198	0.0433	CbGbCtD
Meprobamate—ABCB1—Paclitaxel—breast cancer	0.0179	0.0391	CbGbCtD
Meprobamate—ABCB1—Irinotecan—breast cancer	0.0176	0.0386	CbGbCtD
Meprobamate—ABCB1—Vinblastine—breast cancer	0.0157	0.0343	CbGbCtD
Meprobamate—ABCB1—Docetaxel—breast cancer	0.0129	0.0283	CbGbCtD
Meprobamate—ABCB1—Doxorubicin—breast cancer	0.00963	0.0211	CbGbCtD
Meprobamate—ABCB1—Methotrexate—breast cancer	0.00933	0.0204	CbGbCtD
Meprobamate—Dizziness—Vinblastine—breast cancer	0.0003	0.00119	CcSEcCtD
Meprobamate—Body temperature increased—Vinorelbine—breast cancer	0.000298	0.00118	CcSEcCtD
Meprobamate—Oedema peripheral—Docetaxel—breast cancer	0.000298	0.00118	CcSEcCtD
Meprobamate—Pruritus—Goserelin—breast cancer	0.000298	0.00118	CcSEcCtD
Meprobamate—Anaphylactic shock—Fluorouracil—breast cancer	0.000298	0.00118	CcSEcCtD
Meprobamate—Ataxia—Methotrexate—breast cancer	0.000296	0.00118	CcSEcCtD
Meprobamate—Diarrhoea—Melphalan—breast cancer	0.000295	0.00117	CcSEcCtD
Meprobamate—Nausea—Chlorambucil—breast cancer	0.000294	0.00117	CcSEcCtD
Meprobamate—Dizziness—Tamoxifen—breast cancer	0.000291	0.00116	CcSEcCtD
Meprobamate—Tachycardia—Fluorouracil—breast cancer	0.000291	0.00115	CcSEcCtD
Meprobamate—Hypotension—Irinotecan—breast cancer	0.00029	0.00115	CcSEcCtD
Meprobamate—Hypotension—Mitoxantrone—breast cancer	0.00029	0.00115	CcSEcCtD
Meprobamate—Dermatitis exfoliative—Doxorubicin—breast cancer	0.000289	0.00115	CcSEcCtD
Meprobamate—Oedema peripheral—Capecitabine—breast cancer	0.000288	0.00114	CcSEcCtD
Meprobamate—Vomiting—Vinblastine—breast cancer	0.000288	0.00114	CcSEcCtD
Meprobamate—Diarrhoea—Goserelin—breast cancer	0.000288	0.00114	CcSEcCtD
Meprobamate—Erythema multiforme—Docetaxel—breast cancer	0.000286	0.00113	CcSEcCtD
Meprobamate—Dermatitis bullous—Doxorubicin—breast cancer	0.000285	0.00113	CcSEcCtD
Meprobamate—Agitation—Paclitaxel—breast cancer	0.000285	0.00113	CcSEcCtD
Meprobamate—Body temperature increased—Thiotepa—breast cancer	0.000284	0.00113	CcSEcCtD
Meprobamate—Headache—Vinblastine—breast cancer	0.000284	0.00113	CcSEcCtD
Meprobamate—Angioedema—Paclitaxel—breast cancer	0.000284	0.00113	CcSEcCtD
Meprobamate—Purpura—Doxorubicin—breast cancer	0.000283	0.00112	CcSEcCtD
Meprobamate—Hypotension—Gemcitabine—breast cancer	0.000283	0.00112	CcSEcCtD
Meprobamate—Vomiting—Tamoxifen—breast cancer	0.00028	0.00111	CcSEcCtD
Meprobamate—Paraesthesia—Irinotecan—breast cancer	0.000279	0.00111	CcSEcCtD
Meprobamate—Paraesthesia—Mitoxantrone—breast cancer	0.000279	0.00111	CcSEcCtD
Meprobamate—Vertigo—Paclitaxel—breast cancer	0.000279	0.00111	CcSEcCtD
Meprobamate—Syncope—Paclitaxel—breast cancer	0.000279	0.0011	CcSEcCtD
Meprobamate—Dizziness—Goserelin—breast cancer	0.000278	0.0011	CcSEcCtD
Meprobamate—Hypotension—Fluorouracil—breast cancer	0.000278	0.0011	CcSEcCtD
Meprobamate—Leukopenia—Paclitaxel—breast cancer	0.000278	0.0011	CcSEcCtD
Meprobamate—Hypersensitivity—Vinorelbine—breast cancer	0.000278	0.0011	CcSEcCtD
Meprobamate—Dermatitis—Tamoxifen—breast cancer	0.000277	0.0011	CcSEcCtD
Meprobamate—Ataxia—Epirubicin—breast cancer	0.000277	0.0011	CcSEcCtD
Meprobamate—Erythema multiforme—Capecitabine—breast cancer	0.000277	0.0011	CcSEcCtD
Meprobamate—Somnolence—Mitoxantrone—breast cancer	0.000276	0.0011	CcSEcCtD
Meprobamate—Somnolence—Irinotecan—breast cancer	0.000276	0.0011	CcSEcCtD
Meprobamate—Headache—Tamoxifen—breast cancer	0.000276	0.00109	CcSEcCtD
Meprobamate—Palpitations—Paclitaxel—breast cancer	0.000274	0.00109	CcSEcCtD
Meprobamate—Vomiting—Melphalan—breast cancer	0.000274	0.00109	CcSEcCtD
Meprobamate—Loss of consciousness—Paclitaxel—breast cancer	0.000273	0.00108	CcSEcCtD
Meprobamate—Paraesthesia—Gemcitabine—breast cancer	0.000272	0.00108	CcSEcCtD
Meprobamate—Dermatitis—Melphalan—breast cancer	0.000272	0.00108	CcSEcCtD
Meprobamate—Chills—Docetaxel—breast cancer	0.000271	0.00108	CcSEcCtD
Meprobamate—Asthenia—Vinorelbine—breast cancer	0.00027	0.00107	CcSEcCtD
Meprobamate—Arrhythmia—Docetaxel—breast cancer	0.00027	0.00107	CcSEcCtD
Meprobamate—Eosinophilia—Methotrexate—breast cancer	0.00027	0.00107	CcSEcCtD
Meprobamate—Nausea—Vinblastine—breast cancer	0.000269	0.00107	CcSEcCtD
Meprobamate—Somnolence—Gemcitabine—breast cancer	0.000269	0.00107	CcSEcCtD
Meprobamate—Vomiting—Goserelin—breast cancer	0.000268	0.00106	CcSEcCtD
Meprobamate—Paraesthesia—Fluorouracil—breast cancer	0.000267	0.00106	CcSEcCtD
Meprobamate—Pruritus—Vinorelbine—breast cancer	0.000267	0.00106	CcSEcCtD
Meprobamate—Hypersensitivity—Thiotepa—breast cancer	0.000265	0.00105	CcSEcCtD
Meprobamate—Dermatitis—Goserelin—breast cancer	0.000265	0.00105	CcSEcCtD
Meprobamate—Somnolence—Fluorouracil—breast cancer	0.000265	0.00105	CcSEcCtD
Meprobamate—Headache—Goserelin—breast cancer	0.000264	0.00105	CcSEcCtD
Meprobamate—Chills—Capecitabine—breast cancer	0.000263	0.00104	CcSEcCtD
Meprobamate—Nausea—Tamoxifen—breast cancer	0.000262	0.00104	CcSEcCtD
Meprobamate—Arrhythmia—Capecitabine—breast cancer	0.000262	0.00104	CcSEcCtD
Meprobamate—Asthenia—Thiotepa—breast cancer	0.000258	0.00102	CcSEcCtD
Meprobamate—Diarrhoea—Vinorelbine—breast cancer	0.000258	0.00102	CcSEcCtD
Meprobamate—Ataxia—Doxorubicin—breast cancer	0.000257	0.00102	CcSEcCtD
Meprobamate—Nausea—Melphalan—breast cancer	0.000256	0.00102	CcSEcCtD
Meprobamate—Pruritus—Thiotepa—breast cancer	0.000255	0.00101	CcSEcCtD
Meprobamate—Anaphylactic shock—Paclitaxel—breast cancer	0.000253	0.00101	CcSEcCtD
Meprobamate—Eosinophilia—Epirubicin—breast cancer	0.000252	0.001	CcSEcCtD
Meprobamate—Nausea—Goserelin—breast cancer	0.00025	0.000991	CcSEcCtD
Meprobamate—Shock—Paclitaxel—breast cancer	0.000249	0.000989	CcSEcCtD
Meprobamate—Dizziness—Vinorelbine—breast cancer	0.000249	0.000989	CcSEcCtD
Meprobamate—Tachycardia—Paclitaxel—breast cancer	0.000247	0.000981	CcSEcCtD
Meprobamate—Diarrhoea—Thiotepa—breast cancer	0.000246	0.000977	CcSEcCtD
Meprobamate—Body temperature increased—Mitoxantrone—breast cancer	0.000246	0.000975	CcSEcCtD
Meprobamate—Body temperature increased—Irinotecan—breast cancer	0.000246	0.000975	CcSEcCtD
Meprobamate—Drowsiness—Methotrexate—breast cancer	0.000243	0.000963	CcSEcCtD
Meprobamate—Stevens-Johnson syndrome—Methotrexate—breast cancer	0.000241	0.000955	CcSEcCtD
Meprobamate—Vomiting—Vinorelbine—breast cancer	0.00024	0.000951	CcSEcCtD
Meprobamate—Body temperature increased—Gemcitabine—breast cancer	0.000239	0.000949	CcSEcCtD
Meprobamate—Dizziness—Thiotepa—breast cancer	0.000238	0.000944	CcSEcCtD
Meprobamate—Dermatitis—Vinorelbine—breast cancer	0.000237	0.000942	CcSEcCtD
Meprobamate—Hypotension—Paclitaxel—breast cancer	0.000237	0.00094	CcSEcCtD
Meprobamate—Stomatitis—Methotrexate—breast cancer	0.000237	0.000939	CcSEcCtD
Meprobamate—Headache—Vinorelbine—breast cancer	0.000236	0.000937	CcSEcCtD
Meprobamate—Syncope—Docetaxel—breast cancer	0.000236	0.000937	CcSEcCtD
Meprobamate—Leukopenia—Docetaxel—breast cancer	0.000236	0.000935	CcSEcCtD
Meprobamate—Body temperature increased—Fluorouracil—breast cancer	0.000235	0.000934	CcSEcCtD
Meprobamate—Eosinophilia—Doxorubicin—breast cancer	0.000233	0.000926	CcSEcCtD
Meprobamate—Palpitations—Docetaxel—breast cancer	0.000233	0.000923	CcSEcCtD
Meprobamate—Loss of consciousness—Docetaxel—breast cancer	0.000231	0.000918	CcSEcCtD
Meprobamate—Vertigo—Capecitabine—breast cancer	0.000229	0.000908	CcSEcCtD
Meprobamate—Hypersensitivity—Mitoxantrone—breast cancer	0.000229	0.000908	CcSEcCtD
Meprobamate—Hypersensitivity—Irinotecan—breast cancer	0.000229	0.000908	CcSEcCtD
Meprobamate—Vomiting—Thiotepa—breast cancer	0.000229	0.000908	CcSEcCtD
Meprobamate—Syncope—Capecitabine—breast cancer	0.000229	0.000907	CcSEcCtD
Meprobamate—Leukopenia—Capecitabine—breast cancer	0.000228	0.000905	CcSEcCtD
Meprobamate—Paraesthesia—Paclitaxel—breast cancer	0.000228	0.000903	CcSEcCtD
Meprobamate—Drowsiness—Epirubicin—breast cancer	0.000227	0.000901	CcSEcCtD
Meprobamate—Dermatitis—Thiotepa—breast cancer	0.000227	0.000899	CcSEcCtD
Meprobamate—Agranulocytosis—Methotrexate—breast cancer	0.000227	0.000899	CcSEcCtD
Meprobamate—Headache—Thiotepa—breast cancer	0.000225	0.000894	CcSEcCtD
Meprobamate—Somnolence—Paclitaxel—breast cancer	0.000225	0.000894	CcSEcCtD
Meprobamate—Stevens-Johnson syndrome—Epirubicin—breast cancer	0.000225	0.000894	CcSEcCtD
Meprobamate—Palpitations—Capecitabine—breast cancer	0.000225	0.000894	CcSEcCtD
Meprobamate—Loss of consciousness—Capecitabine—breast cancer	0.000224	0.000889	CcSEcCtD
Meprobamate—Nausea—Vinorelbine—breast cancer	0.000224	0.000888	CcSEcCtD
Meprobamate—Asthenia—Mitoxantrone—breast cancer	0.000223	0.000885	CcSEcCtD
Meprobamate—Asthenia—Irinotecan—breast cancer	0.000223	0.000885	CcSEcCtD
Meprobamate—Stomatitis—Epirubicin—breast cancer	0.000221	0.000879	CcSEcCtD
Meprobamate—Hypersensitivity—Fluorouracil—breast cancer	0.000219	0.00087	CcSEcCtD
Meprobamate—Asthenia—Gemcitabine—breast cancer	0.000217	0.000862	CcSEcCtD
Meprobamate—Anaphylactic shock—Docetaxel—breast cancer	0.000215	0.000852	CcSEcCtD
Meprobamate—Pruritus—Gemcitabine—breast cancer	0.000214	0.00085	CcSEcCtD
Meprobamate—Nausea—Thiotepa—breast cancer	0.000214	0.000848	CcSEcCtD
Meprobamate—Diarrhoea—Mitoxantrone—breast cancer	0.000213	0.000844	CcSEcCtD
Meprobamate—Diarrhoea—Irinotecan—breast cancer	0.000213	0.000844	CcSEcCtD
Meprobamate—Agranulocytosis—Epirubicin—breast cancer	0.000212	0.000841	CcSEcCtD
Meprobamate—Shock—Docetaxel—breast cancer	0.000211	0.000839	CcSEcCtD
Meprobamate—Pruritus—Fluorouracil—breast cancer	0.000211	0.000835	CcSEcCtD
Meprobamate—Drowsiness—Doxorubicin—breast cancer	0.00021	0.000834	CcSEcCtD
Meprobamate—Tachycardia—Docetaxel—breast cancer	0.00021	0.000832	CcSEcCtD
Meprobamate—Stevens-Johnson syndrome—Doxorubicin—breast cancer	0.000208	0.000827	CcSEcCtD
Meprobamate—Diarrhoea—Gemcitabine—breast cancer	0.000207	0.000822	CcSEcCtD
Meprobamate—Erythema multiforme—Methotrexate—breast cancer	0.000206	0.000818	CcSEcCtD
Meprobamate—Dizziness—Irinotecan—breast cancer	0.000206	0.000815	CcSEcCtD
Meprobamate—Stomatitis—Doxorubicin—breast cancer	0.000205	0.000813	CcSEcCtD
Meprobamate—Shock—Capecitabine—breast cancer	0.000205	0.000812	CcSEcCtD
Meprobamate—Diarrhoea—Fluorouracil—breast cancer	0.000204	0.000808	CcSEcCtD
Meprobamate—Tachycardia—Capecitabine—breast cancer	0.000203	0.000805	CcSEcCtD
Meprobamate—Oedema peripheral—Epirubicin—breast cancer	0.000201	0.000797	CcSEcCtD
Meprobamate—Hypotension—Docetaxel—breast cancer	0.000201	0.000796	CcSEcCtD
Meprobamate—Body temperature increased—Paclitaxel—breast cancer	0.0002	0.000795	CcSEcCtD
Meprobamate—Vomiting—Irinotecan—breast cancer	0.000198	0.000784	CcSEcCtD
Meprobamate—Vomiting—Mitoxantrone—breast cancer	0.000198	0.000784	CcSEcCtD
Meprobamate—Dizziness—Fluorouracil—breast cancer	0.000197	0.000781	CcSEcCtD
Meprobamate—Agranulocytosis—Doxorubicin—breast cancer	0.000196	0.000778	CcSEcCtD
Meprobamate—Dermatitis—Irinotecan—breast cancer	0.000196	0.000777	CcSEcCtD
Meprobamate—Dermatitis—Mitoxantrone—breast cancer	0.000196	0.000777	CcSEcCtD
Meprobamate—Chills—Methotrexate—breast cancer	0.000196	0.000776	CcSEcCtD
Meprobamate—Headache—Irinotecan—breast cancer	0.000195	0.000772	CcSEcCtD
Meprobamate—Headache—Mitoxantrone—breast cancer	0.000195	0.000772	CcSEcCtD
Meprobamate—Hypotension—Capecitabine—breast cancer	0.000194	0.000771	CcSEcCtD
Meprobamate—Paraesthesia—Docetaxel—breast cancer	0.000193	0.000765	CcSEcCtD
Meprobamate—Erythema multiforme—Epirubicin—breast cancer	0.000193	0.000765	CcSEcCtD
Meprobamate—Vomiting—Gemcitabine—breast cancer	0.000192	0.000764	CcSEcCtD
Meprobamate—Somnolence—Docetaxel—breast cancer	0.000191	0.000758	CcSEcCtD
Meprobamate—Dermatitis—Gemcitabine—breast cancer	0.000191	0.000757	CcSEcCtD
Meprobamate—Headache—Gemcitabine—breast cancer	0.00019	0.000752	CcSEcCtD
Meprobamate—Vomiting—Fluorouracil—breast cancer	0.000189	0.000751	CcSEcCtD
Meprobamate—Dermatitis—Fluorouracil—breast cancer	0.000188	0.000744	CcSEcCtD
Meprobamate—Paraesthesia—Capecitabine—breast cancer	0.000187	0.000741	CcSEcCtD
Meprobamate—Hypersensitivity—Paclitaxel—breast cancer	0.000187	0.000741	CcSEcCtD
Meprobamate—Headache—Fluorouracil—breast cancer	0.000186	0.00074	CcSEcCtD
Meprobamate—Oedema peripheral—Doxorubicin—breast cancer	0.000186	0.000738	CcSEcCtD
Meprobamate—Nausea—Mitoxantrone—breast cancer	0.000185	0.000732	CcSEcCtD
Meprobamate—Nausea—Irinotecan—breast cancer	0.000185	0.000732	CcSEcCtD
Meprobamate—Chills—Epirubicin—breast cancer	0.000183	0.000726	CcSEcCtD
Meprobamate—Arrhythmia—Epirubicin—breast cancer	0.000182	0.000723	CcSEcCtD
Meprobamate—Asthenia—Paclitaxel—breast cancer	0.000182	0.000721	CcSEcCtD
Meprobamate—Nausea—Gemcitabine—breast cancer	0.00018	0.000713	CcSEcCtD
Meprobamate—Pruritus—Paclitaxel—breast cancer	0.000179	0.000711	CcSEcCtD
Meprobamate—Erythema multiforme—Doxorubicin—breast cancer	0.000178	0.000708	CcSEcCtD
Meprobamate—Nausea—Fluorouracil—breast cancer	0.000177	0.000701	CcSEcCtD
Meprobamate—Diarrhoea—Paclitaxel—breast cancer	0.000173	0.000688	CcSEcCtD
Meprobamate—Vertigo—Methotrexate—breast cancer	0.00017	0.000676	CcSEcCtD
Meprobamate—Body temperature increased—Docetaxel—breast cancer	0.00017	0.000674	CcSEcCtD
Meprobamate—Leukopenia—Methotrexate—breast cancer	0.00017	0.000674	CcSEcCtD
Meprobamate—Chills—Doxorubicin—breast cancer	0.000169	0.000672	CcSEcCtD
Meprobamate—Arrhythmia—Doxorubicin—breast cancer	0.000169	0.000669	CcSEcCtD
Meprobamate—Dizziness—Paclitaxel—breast cancer	0.000168	0.000665	CcSEcCtD
Meprobamate—Body temperature increased—Capecitabine—breast cancer	0.000164	0.000652	CcSEcCtD
Meprobamate—Agitation—Epirubicin—breast cancer	0.000163	0.000647	CcSEcCtD
Meprobamate—Vomiting—Paclitaxel—breast cancer	0.000161	0.000639	CcSEcCtD
Meprobamate—Dermatitis—Paclitaxel—breast cancer	0.00016	0.000633	CcSEcCtD
Meprobamate—Vertigo—Epirubicin—breast cancer	0.00016	0.000633	CcSEcCtD
Meprobamate—Syncope—Epirubicin—breast cancer	0.000159	0.000632	CcSEcCtD
Meprobamate—Leukopenia—Epirubicin—breast cancer	0.000159	0.000631	CcSEcCtD
Meprobamate—Headache—Paclitaxel—breast cancer	0.000159	0.00063	CcSEcCtD
Meprobamate—Hypersensitivity—Docetaxel—breast cancer	0.000158	0.000628	CcSEcCtD
Meprobamate—Palpitations—Epirubicin—breast cancer	0.000157	0.000622	CcSEcCtD
Meprobamate—Loss of consciousness—Epirubicin—breast cancer	0.000156	0.000619	CcSEcCtD
Meprobamate—Anaphylactic shock—Methotrexate—breast cancer	0.000155	0.000614	CcSEcCtD
Meprobamate—Asthenia—Docetaxel—breast cancer	0.000154	0.000612	CcSEcCtD
Meprobamate—Hypersensitivity—Capecitabine—breast cancer	0.000153	0.000608	CcSEcCtD
Meprobamate—Pruritus—Docetaxel—breast cancer	0.000152	0.000603	CcSEcCtD
Meprobamate—Agitation—Doxorubicin—breast cancer	0.000151	0.000599	CcSEcCtD
Meprobamate—Nausea—Paclitaxel—breast cancer	0.000151	0.000597	CcSEcCtD
Meprobamate—Asthenia—Capecitabine—breast cancer	0.000149	0.000592	CcSEcCtD
Meprobamate—Vertigo—Doxorubicin—breast cancer	0.000148	0.000586	CcSEcCtD
Meprobamate—Syncope—Doxorubicin—breast cancer	0.000147	0.000584	CcSEcCtD
Meprobamate—Pruritus—Capecitabine—breast cancer	0.000147	0.000584	CcSEcCtD
Meprobamate—Leukopenia—Doxorubicin—breast cancer	0.000147	0.000583	CcSEcCtD
Meprobamate—Diarrhoea—Docetaxel—breast cancer	0.000147	0.000583	CcSEcCtD
Meprobamate—Palpitations—Doxorubicin—breast cancer	0.000145	0.000576	CcSEcCtD
Meprobamate—Anaphylactic shock—Epirubicin—breast cancer	0.000145	0.000575	CcSEcCtD
Meprobamate—Hypotension—Methotrexate—breast cancer	0.000145	0.000574	CcSEcCtD
Meprobamate—Loss of consciousness—Doxorubicin—breast cancer	0.000144	0.000573	CcSEcCtD
Meprobamate—Shock—Epirubicin—breast cancer	0.000143	0.000566	CcSEcCtD
Meprobamate—Diarrhoea—Capecitabine—breast cancer	0.000142	0.000565	CcSEcCtD
Meprobamate—Dizziness—Docetaxel—breast cancer	0.000142	0.000564	CcSEcCtD
Meprobamate—Tachycardia—Epirubicin—breast cancer	0.000141	0.000561	CcSEcCtD
Meprobamate—Paraesthesia—Methotrexate—breast cancer	0.000139	0.000552	CcSEcCtD
Meprobamate—Somnolence—Methotrexate—breast cancer	0.000138	0.000546	CcSEcCtD
Meprobamate—Dizziness—Capecitabine—breast cancer	0.000138	0.000546	CcSEcCtD
Meprobamate—Vomiting—Docetaxel—breast cancer	0.000137	0.000542	CcSEcCtD
Meprobamate—Hypotension—Epirubicin—breast cancer	0.000135	0.000537	CcSEcCtD
Meprobamate—Dermatitis—Docetaxel—breast cancer	0.000135	0.000537	CcSEcCtD
Meprobamate—Headache—Docetaxel—breast cancer	0.000135	0.000534	CcSEcCtD
Meprobamate—Anaphylactic shock—Doxorubicin—breast cancer	0.000134	0.000532	CcSEcCtD
Meprobamate—Vomiting—Capecitabine—breast cancer	0.000132	0.000525	CcSEcCtD
Meprobamate—Shock—Doxorubicin—breast cancer	0.000132	0.000523	CcSEcCtD
Meprobamate—Dermatitis—Capecitabine—breast cancer	0.000131	0.00052	CcSEcCtD
Meprobamate—Tachycardia—Doxorubicin—breast cancer	0.000131	0.000519	CcSEcCtD
Meprobamate—Headache—Capecitabine—breast cancer	0.00013	0.000517	CcSEcCtD
Meprobamate—Paraesthesia—Epirubicin—breast cancer	0.00013	0.000516	CcSEcCtD
Meprobamate—Somnolence—Epirubicin—breast cancer	0.000129	0.000511	CcSEcCtD
Meprobamate—Nausea—Docetaxel—breast cancer	0.000128	0.000506	CcSEcCtD
Meprobamate—Hypotension—Doxorubicin—breast cancer	0.000125	0.000497	CcSEcCtD
Meprobamate—Nausea—Capecitabine—breast cancer	0.000124	0.00049	CcSEcCtD
Meprobamate—Body temperature increased—Methotrexate—breast cancer	0.000122	0.000486	CcSEcCtD
Meprobamate—Paraesthesia—Doxorubicin—breast cancer	0.00012	0.000478	CcSEcCtD
Meprobamate—Somnolence—Doxorubicin—breast cancer	0.000119	0.000473	CcSEcCtD
Meprobamate—Body temperature increased—Epirubicin—breast cancer	0.000115	0.000454	CcSEcCtD
Meprobamate—Hypersensitivity—Methotrexate—breast cancer	0.000114	0.000453	CcSEcCtD
Meprobamate—Asthenia—Methotrexate—breast cancer	0.000111	0.000441	CcSEcCtD
Meprobamate—Pruritus—Methotrexate—breast cancer	0.00011	0.000435	CcSEcCtD
Meprobamate—Hypersensitivity—Epirubicin—breast cancer	0.000107	0.000424	CcSEcCtD
Meprobamate—Body temperature increased—Doxorubicin—breast cancer	0.000106	0.00042	CcSEcCtD
Meprobamate—Diarrhoea—Methotrexate—breast cancer	0.000106	0.00042	CcSEcCtD
Meprobamate—Asthenia—Epirubicin—breast cancer	0.000104	0.000412	CcSEcCtD
Meprobamate—Pruritus—Epirubicin—breast cancer	0.000103	0.000407	CcSEcCtD
Meprobamate—Dizziness—Methotrexate—breast cancer	0.000102	0.000406	CcSEcCtD
Meprobamate—Diarrhoea—Epirubicin—breast cancer	9.91e-05	0.000393	CcSEcCtD
Meprobamate—Hypersensitivity—Doxorubicin—breast cancer	9.88e-05	0.000392	CcSEcCtD
Meprobamate—Vomiting—Methotrexate—breast cancer	9.85e-05	0.000391	CcSEcCtD
Meprobamate—Dermatitis—Methotrexate—breast cancer	9.75e-05	0.000387	CcSEcCtD
Meprobamate—Headache—Methotrexate—breast cancer	9.7e-05	0.000385	CcSEcCtD
Meprobamate—Asthenia—Doxorubicin—breast cancer	9.62e-05	0.000382	CcSEcCtD
Meprobamate—Dizziness—Epirubicin—breast cancer	9.58e-05	0.00038	CcSEcCtD
Meprobamate—Pruritus—Doxorubicin—breast cancer	9.49e-05	0.000376	CcSEcCtD
Meprobamate—Vomiting—Epirubicin—breast cancer	9.21e-05	0.000366	CcSEcCtD
Meprobamate—Nausea—Methotrexate—breast cancer	9.2e-05	0.000365	CcSEcCtD
Meprobamate—Diarrhoea—Doxorubicin—breast cancer	9.17e-05	0.000364	CcSEcCtD
Meprobamate—Dermatitis—Epirubicin—breast cancer	9.13e-05	0.000362	CcSEcCtD
Meprobamate—Headache—Epirubicin—breast cancer	9.08e-05	0.00036	CcSEcCtD
Meprobamate—Dizziness—Doxorubicin—breast cancer	8.87e-05	0.000352	CcSEcCtD
Meprobamate—Nausea—Epirubicin—breast cancer	8.61e-05	0.000341	CcSEcCtD
Meprobamate—Vomiting—Doxorubicin—breast cancer	8.53e-05	0.000338	CcSEcCtD
Meprobamate—Dermatitis—Doxorubicin—breast cancer	8.45e-05	0.000335	CcSEcCtD
Meprobamate—Headache—Doxorubicin—breast cancer	8.4e-05	0.000333	CcSEcCtD
Meprobamate—Nausea—Doxorubicin—breast cancer	7.96e-05	0.000316	CcSEcCtD
Meprobamate—CYP2C19—Metabolism—HADHB—breast cancer	1.96e-05	0.00018	CbGpPWpGaD
Meprobamate—GABRG2—Transmembrane transport of small molecules—RAF1—breast cancer	1.93e-05	0.000179	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—GPX2—breast cancer	1.92e-05	0.000177	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—GSTA2—breast cancer	1.92e-05	0.000177	CbGpPWpGaD
Meprobamate—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—breast cancer	1.92e-05	0.000177	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—HADHB—breast cancer	1.91e-05	0.000176	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—GPI—breast cancer	1.91e-05	0.000176	CbGpPWpGaD
Meprobamate—ABCB1—Transmembrane transport of small molecules—SLC2A1—breast cancer	1.9e-05	0.000175	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—GPX4—breast cancer	1.9e-05	0.000175	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—SULT1A1—breast cancer	1.9e-05	0.000175	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism of lipids and lipoproteins—NCOA1—breast cancer	1.87e-05	0.000173	CbGpPWpGaD
Meprobamate—GABRA1—Transmembrane transport of small molecules—ALB—breast cancer	1.87e-05	0.000173	CbGpPWpGaD
Meprobamate—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—breast cancer	1.87e-05	0.000172	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—ALDH7A1—breast cancer	1.87e-05	0.000172	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—ALDH1A1—breast cancer	1.87e-05	0.000172	CbGpPWpGaD
Meprobamate—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—breast cancer	1.86e-05	0.000172	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—GSTA1—breast cancer	1.85e-05	0.000171	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—IDH1—breast cancer	1.85e-05	0.000171	CbGpPWpGaD
Meprobamate—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—breast cancer	1.85e-05	0.000171	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—breast cancer	1.84e-05	0.00017	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—NAT2—breast cancer	1.83e-05	0.000169	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—ALDH1A1—breast cancer	1.82e-05	0.000168	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—ALDH7A1—breast cancer	1.82e-05	0.000168	CbGpPWpGaD
Meprobamate—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—breast cancer	1.81e-05	0.000167	CbGpPWpGaD
Meprobamate—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—breast cancer	1.8e-05	0.000166	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—ADSL—breast cancer	1.79e-05	0.000165	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—PHGDH—breast cancer	1.79e-05	0.000165	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—UMPS—breast cancer	1.79e-05	0.000165	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—FHL2—breast cancer	1.79e-05	0.000165	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—NME1—breast cancer	1.79e-05	0.000165	CbGpPWpGaD
Meprobamate—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—breast cancer	1.76e-05	0.000163	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—HPSE—breast cancer	1.75e-05	0.000162	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—BRIP1—breast cancer	1.75e-05	0.000162	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—LDHB—breast cancer	1.75e-05	0.000162	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—FHL2—breast cancer	1.75e-05	0.000161	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—PHGDH—breast cancer	1.75e-05	0.000161	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—NME1—breast cancer	1.75e-05	0.000161	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—ADSL—breast cancer	1.75e-05	0.000161	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—UMPS—breast cancer	1.75e-05	0.000161	CbGpPWpGaD
Meprobamate—ABCB1—Transmembrane transport of small molecules—NCOA1—breast cancer	1.74e-05	0.00016	CbGpPWpGaD
Meprobamate—GABRA1—Neuronal System—HRAS—breast cancer	1.73e-05	0.00016	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—BRIP1—breast cancer	1.71e-05	0.000158	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—HPSE—breast cancer	1.71e-05	0.000158	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—LDHB—breast cancer	1.71e-05	0.000158	CbGpPWpGaD
Meprobamate—ABCB1—Transmembrane transport of small molecules—PLG—breast cancer	1.69e-05	0.000156	CbGpPWpGaD
Meprobamate—GABRA1—Transmembrane transport of small molecules—RAF1—breast cancer	1.69e-05	0.000156	CbGpPWpGaD
Meprobamate—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—breast cancer	1.67e-05	0.000154	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—GSTA3—breast cancer	1.66e-05	0.000153	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—HMMR—breast cancer	1.66e-05	0.000153	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—ABCC1—breast cancer	1.66e-05	0.000153	CbGpPWpGaD
Meprobamate—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—breast cancer	1.63e-05	0.00015	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—ABCC1—breast cancer	1.62e-05	0.00015	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—HMMR—breast cancer	1.62e-05	0.00015	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—GSTA3—breast cancer	1.62e-05	0.00015	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—PPARGC1B—breast cancer	1.61e-05	0.000149	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—DPYD—breast cancer	1.61e-05	0.000148	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—MED12—breast cancer	1.61e-05	0.000148	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—ALDOA—breast cancer	1.58e-05	0.000146	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—PPARGC1B—breast cancer	1.57e-05	0.000145	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—breast cancer	1.57e-05	0.000145	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G4A—breast cancer	1.57e-05	0.000145	CbGpPWpGaD
Meprobamate—ABCB1—Transmembrane transport of small molecules—HMOX1—breast cancer	1.56e-05	0.000144	CbGpPWpGaD
Meprobamate—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—breast cancer	1.54e-05	0.000142	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—NCOA3—breast cancer	1.54e-05	0.000142	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—SLC2A2—breast cancer	1.52e-05	0.000141	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—CA9—breast cancer	1.52e-05	0.00014	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—GSTA4—breast cancer	1.52e-05	0.00014	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—breast cancer	1.5e-05	0.000139	CbGpPWpGaD
Meprobamate—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—breast cancer	1.5e-05	0.000138	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—CPT1A—breast cancer	1.49e-05	0.000138	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—ABCG2—breast cancer	1.49e-05	0.000138	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—MTR—breast cancer	1.49e-05	0.000138	CbGpPWpGaD
Meprobamate—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—breast cancer	1.49e-05	0.000138	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—breast cancer	1.49e-05	0.000137	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—CA9—breast cancer	1.48e-05	0.000137	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—GSTA4—breast cancer	1.48e-05	0.000137	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—GSTA2—breast cancer	1.48e-05	0.000137	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—GPX2—breast cancer	1.48e-05	0.000137	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—HPGDS—breast cancer	1.46e-05	0.000135	CbGpPWpGaD
Meprobamate—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—breast cancer	1.46e-05	0.000135	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—GPX4—breast cancer	1.46e-05	0.000135	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—SULT1A1—breast cancer	1.46e-05	0.000135	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—HBA1—breast cancer	1.46e-05	0.000134	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—GSTA2—breast cancer	1.45e-05	0.000133	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—GPX2—breast cancer	1.45e-05	0.000133	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—IDH1—breast cancer	1.43e-05	0.000132	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—GSTA1—breast cancer	1.43e-05	0.000132	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—SULT1A1—breast cancer	1.43e-05	0.000132	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—GPX4—breast cancer	1.43e-05	0.000132	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—GSTT1—breast cancer	1.42e-05	0.000131	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—ACHE—breast cancer	1.42e-05	0.000131	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—NAT2—breast cancer	1.41e-05	0.00013	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—IDH1—breast cancer	1.4e-05	0.000129	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—GSTA1—breast cancer	1.4e-05	0.000129	CbGpPWpGaD
Meprobamate—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—breast cancer	1.39e-05	0.000129	CbGpPWpGaD
Meprobamate—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—breast cancer	1.38e-05	0.000128	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—NAT2—breast cancer	1.38e-05	0.000127	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—CYP17A1—breast cancer	1.34e-05	0.000124	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—ENO1—breast cancer	1.33e-05	0.000123	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—PTGS1—breast cancer	1.33e-05	0.000123	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—CYP2D6—breast cancer	1.31e-05	0.000121	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—NCOA2—breast cancer	1.28e-05	0.000118	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—breast cancer	1.28e-05	0.000118	CbGpPWpGaD
Meprobamate—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—breast cancer	1.27e-05	0.000117	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—FASN—breast cancer	1.24e-05	0.000115	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—DPYD—breast cancer	1.24e-05	0.000114	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—MED12—breast cancer	1.24e-05	0.000114	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—BCHE—breast cancer	1.24e-05	0.000114	CbGpPWpGaD
Meprobamate—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—breast cancer	1.23e-05	0.000113	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—SLC5A5—breast cancer	1.22e-05	0.000113	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—ALDOA—breast cancer	1.22e-05	0.000113	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—MED12—breast cancer	1.21e-05	0.000112	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—DPYD—breast cancer	1.21e-05	0.000112	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—ALDOA—breast cancer	1.19e-05	0.00011	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—NCOA3—breast cancer	1.18e-05	0.000109	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—NQO1—breast cancer	1.18e-05	0.000109	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—SLC2A1—breast cancer	1.18e-05	0.000109	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—SLC2A2—breast cancer	1.18e-05	0.000109	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	1.16e-05	0.000107	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—NCOA3—breast cancer	1.16e-05	0.000107	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—MTR—breast cancer	1.15e-05	0.000106	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—CPT1A—breast cancer	1.15e-05	0.000106	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—ABCG2—breast cancer	1.15e-05	0.000106	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—CYP3A4—breast cancer	1.15e-05	0.000106	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—SLC2A2—breast cancer	1.15e-05	0.000106	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—CYP1B1—breast cancer	1.13e-05	0.000104	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—HPGDS—breast cancer	1.13e-05	0.000104	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—MTR—breast cancer	1.12e-05	0.000104	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—CPT1A—breast cancer	1.12e-05	0.000104	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—ABCG2—breast cancer	1.12e-05	0.000104	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—HBA1—breast cancer	1.12e-05	0.000104	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—HSP90AA1—breast cancer	1.11e-05	0.000102	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—HPGDS—breast cancer	1.1e-05	0.000102	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—HBA1—breast cancer	1.1e-05	0.000101	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—ACHE—breast cancer	1.1e-05	0.000101	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—GSTT1—breast cancer	1.1e-05	0.000101	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—NCOA1—breast cancer	1.08e-05	9.97e-05	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—GSTT1—breast cancer	1.07e-05	9.87e-05	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—ACHE—breast cancer	1.07e-05	9.87e-05	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—STK11—breast cancer	1.06e-05	9.82e-05	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—CYP19A1—breast cancer	1.06e-05	9.82e-05	CbGpPWpGaD
Meprobamate—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—breast cancer	1.04e-05	9.58e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—CYP17A1—breast cancer	1.04e-05	9.58e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—ENO1—breast cancer	1.03e-05	9.48e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—PTGS1—breast cancer	1.03e-05	9.48e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	1.02e-05	9.45e-05	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—CYP17A1—breast cancer	1.01e-05	9.35e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism of lipids and lipoproteins—ALB—breast cancer	1.01e-05	9.32e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—CYP2D6—breast cancer	1.01e-05	9.3e-05	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—PTGS1—breast cancer	1e-05	9.25e-05	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—ENO1—breast cancer	1e-05	9.25e-05	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—COMT—breast cancer	9.89e-06	9.13e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—NCOA2—breast cancer	9.89e-06	9.13e-05	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—GSTP1—breast cancer	9.85e-06	9.09e-05	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—CYP2D6—breast cancer	9.83e-06	9.07e-05	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—HMOX1—breast cancer	9.71e-06	8.96e-05	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—ITPR1—breast cancer	9.69e-06	8.94e-05	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—NCOA2—breast cancer	9.65e-06	8.91e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—FASN—breast cancer	9.59e-06	8.85e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—BCHE—breast cancer	9.55e-06	8.81e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—SLC5A5—breast cancer	9.43e-06	8.71e-05	CbGpPWpGaD
Meprobamate—ABCB1—Transmembrane transport of small molecules—ALB—breast cancer	9.37e-06	8.65e-05	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—FASN—breast cancer	9.36e-06	8.64e-05	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—ABCB1—breast cancer	9.32e-06	8.6e-05	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—BCHE—breast cancer	9.32e-06	8.6e-05	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—SLC5A5—breast cancer	9.2e-06	8.5e-05	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—TYMS—breast cancer	9.15e-06	8.45e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—SLC2A1—breast cancer	9.11e-06	8.41e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—NQO1—breast cancer	9.11e-06	8.41e-05	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—PLA2G4A—breast cancer	9.05e-06	8.35e-05	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—NCOR1—breast cancer	9.05e-06	8.35e-05	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—GSTM1—breast cancer	9.05e-06	8.35e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	8.92e-06	8.23e-05	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—SLC2A1—breast cancer	8.89e-06	8.21e-05	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—NQO1—breast cancer	8.89e-06	8.21e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—CYP3A4—breast cancer	8.88e-06	8.2e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	8.84e-06	8.16e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—CYP1B1—breast cancer	8.73e-06	8.06e-05	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—CYP3A4—breast cancer	8.67e-06	8e-05	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—GPX1—breast cancer	8.67e-06	8e-05	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—CYP1A1—breast cancer	8.58e-06	7.92e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—HSP90AA1—breast cancer	8.56e-06	7.91e-05	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—CYP1B1—breast cancer	8.52e-06	7.87e-05	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—ERCC2—breast cancer	8.51e-06	7.85e-05	CbGpPWpGaD
Meprobamate—ABCB1—Transmembrane transport of small molecules—RAF1—breast cancer	8.48e-06	7.83e-05	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—HSP90AA1—breast cancer	8.36e-06	7.72e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—NCOA1—breast cancer	8.33e-06	7.69e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—CYP19A1—breast cancer	8.21e-06	7.58e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—STK11—breast cancer	8.21e-06	7.58e-05	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—NCOA1—breast cancer	8.13e-06	7.51e-05	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—STK11—breast cancer	8.01e-06	7.4e-05	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—CYP19A1—breast cancer	8.01e-06	7.4e-05	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—MTHFR—breast cancer	8e-06	7.38e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—breast cancer	7.71e-06	7.11e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—COMT—breast cancer	7.63e-06	7.05e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—GSTP1—breast cancer	7.6e-06	7.01e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—HMOX1—breast cancer	7.49e-06	6.92e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—ITPR1—breast cancer	7.48e-06	6.9e-05	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—COMT—breast cancer	7.45e-06	6.88e-05	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—GSTP1—breast cancer	7.41e-06	6.84e-05	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—CAV1—breast cancer	7.38e-06	6.81e-05	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—HMOX1—breast cancer	7.31e-06	6.75e-05	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—ITPR1—breast cancer	7.3e-06	6.73e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—ABCB1—breast cancer	7.19e-06	6.64e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—TYMS—breast cancer	7.06e-06	6.52e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—NCOR1—breast cancer	6.98e-06	6.44e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—PLA2G4A—breast cancer	6.98e-06	6.44e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—GSTM1—breast cancer	6.98e-06	6.44e-05	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—TYMS—breast cancer	6.89e-06	6.36e-05	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—GSTM1—breast cancer	6.81e-06	6.29e-05	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—NCOR1—breast cancer	6.81e-06	6.29e-05	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—PLA2G4A—breast cancer	6.81e-06	6.29e-05	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—PIK3CG—breast cancer	6.72e-06	6.2e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—GPX1—breast cancer	6.69e-06	6.17e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—CYP1A1—breast cancer	6.62e-06	6.11e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—ERCC2—breast cancer	6.56e-06	6.06e-05	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—GPX1—breast cancer	6.53e-06	6.02e-05	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—CYP1A1—breast cancer	6.46e-06	5.96e-05	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—ERCC2—breast cancer	6.41e-06	5.91e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—MTHFR—breast cancer	6.17e-06	5.7e-05	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—MTHFR—breast cancer	6.02e-06	5.56e-05	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—PIK3CD—breast cancer	5.91e-06	5.45e-05	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—ALB—breast cancer	5.83e-06	5.38e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—CAV1—breast cancer	5.69e-06	5.25e-05	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—NOS3—breast cancer	5.58e-06	5.15e-05	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—CAV1—breast cancer	5.55e-06	5.13e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	5.44e-06	5.02e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—PIK3CG—breast cancer	5.18e-06	4.79e-05	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—PIK3CB—breast cancer	5.15e-06	4.75e-05	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—PTGS2—breast cancer	5.1e-06	4.71e-05	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—PIK3CG—breast cancer	5.06e-06	4.67e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—PIK3CD—breast cancer	4.56e-06	4.21e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—ALB—breast cancer	4.5e-06	4.15e-05	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—PTEN—breast cancer	4.45e-06	4.11e-05	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—PIK3CD—breast cancer	4.45e-06	4.11e-05	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—ALB—breast cancer	4.39e-06	4.05e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—NOS3—breast cancer	4.3e-06	3.97e-05	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—NOS3—breast cancer	4.2e-06	3.88e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—PIK3CB—breast cancer	3.97e-06	3.67e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—PTGS2—breast cancer	3.94e-06	3.63e-05	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—PIK3CB—breast cancer	3.88e-06	3.58e-05	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—PTGS2—breast cancer	3.84e-06	3.55e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—PTEN—breast cancer	3.43e-06	3.17e-05	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—PTEN—breast cancer	3.35e-06	3.09e-05	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—PIK3CA—breast cancer	3.14e-06	2.9e-05	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—AKT1—breast cancer	2.56e-06	2.37e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—PIK3CA—breast cancer	2.42e-06	2.24e-05	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—PIK3CA—breast cancer	2.36e-06	2.18e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—AKT1—breast cancer	1.98e-06	1.83e-05	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—AKT1—breast cancer	1.93e-06	1.78e-05	CbGpPWpGaD
